What long-term monitoring is indicated in the treatment of polyarteritis nodosa (PAN)?

Updated: Nov 14, 2017
  • Author: Dana Jacobs-Kosmin, MD, FACP; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Answer

Patients with polyarteritis nodosa (PAN) should be monitored closely for evidence of relapse or symptoms indicating new organ involvement. Cyclophosphamide dosing should be adjusted according to the level of immunosuppression. The patient’s complete blood count (CBC) should be checked 10-14 days after IV cyclophosphamide is administered and every 2 weeks once oral cyclophosphamide is initiated.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!